Re: Farmas USA
He subido esto por la gente que aun la lleva o la esta tradeando. yo no me acerco.
XOMA
He subido esto por la gente que aun la lleva o la esta tradeando. yo no me acerco.
XOMA
Menuda semana tenemos por delante:
- Aug retail sales report Tue;
- consumer price index Wed;
- housing report Thur;
- fed meeting Wed & Thur;
- quad witching Fri
XOMA
No sé si se publicó por aquí, pero el otro día leí que Nasdaq había comunicado a Xoma que iniciaba un proceso de-listing por llevar demasiado tiempo cotizando por debajo de $1. No era algo immediato, pero lo ponían en marcha.
Edito: esta es la noticia...
XOMA Corporation Receives Non-Compliance Letter From NASDAQ
(Bloomberg / Sep 4th)
XOMA Corporation received a letter from the staff of The NASDAQ Stock Market LLC (“NASDAQ”) on September 4, 2015 providing notification that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Global Market under NASDAQ’s Listing Rule 5450(a)(1), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the NASDAQ Global Market. In accordance with Nasdaq Listing Rule 5810(c)(3)(A) , if during the 180 calendar days following the date of the notification, or prior to March 2, 2016, the closing bid price of the Company’s common stock is at or above $1.00 for a minimum of 10 consecutive business days, the Staff will provide the Company with written confirmation of compliance. If the Company does not achieve compliance with the Minimum Bid Price Requirement by March 2, 2016, the Company may be eligible for an additional 180 calendar days compliance period if it elects to transfer to the Nasdaq Capital Market, so as to take advantage of the additional compliance period offered on that market. To qualify, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, the Staff would notify the Company that its securities would be subject to delisting. In the event of such notification, the Company may appeal the Staff’s determination to delist its securities, but there can be no assurance the Staff would grant the Company’s request for continued listing. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider implementing available options to regain compliance with the Minimum Bid Price Requirement under the NASDAQ Listing Rules.
Gracias Framus....y Trantor
A tope, guardad balas chicos.
El 09/29 tenemos evento en NVAX, correcto?
Estoy buscando en la página en investors y aparecen last events pero no veo futuros...
Es lo usual. Ya lo hemos visto en otras ocasiones.
Tienen 180 dias para volver por encima de 1$ ...
XOMA
Si, la reunion anual de inversores y analistas. Siempre es por estas fechasZ
Antes caera la new del RSV materno.
NVAX
PRSN os la traje por aquí hace días. Mugi, Sietesoles y yo hemos hablado de ella en Otras aventuras de Farmas USA.
https://www.rankia.com/foros/bolsa/temas/2610198-otras-aventuras-farmas-usa?page=448
yo tendría mucho cuidado (no digo que no pueda subir). Es mas creo que puede subir y mucho. Está caliente y Fonsietrader se ha sumado.
Es una microfarma (bueno de farma tiene poco) pero micro, micro si que es.
Resumiendo, creo que todo viene de un trimestre,el último, con muy buenas ventas. Si vuelven a vender este trimestre igual y la gente empieza a creer en su maquinita, se va a ir arriba con fuerza. Ahora, también hay que recordar que a parte de la maquinita no tienen otra cosa.